Table 2.
Low-grade glioma | High-grade glioma | p | |
---|---|---|---|
Age in years | 33.2 ± 9.2 (24–45) | 55.3 ± 11.9 (44–78) | < 0.01 |
Men, n (%) | 2 (28.6) | 4 (57.1) | 0.59 |
Lesion size in mm | 44.4 ± 19.1 (23.1–68.7) | 27.1 ± 17.2 (6.4–56.4) | 0.13 |
IDH1 R132Ha, n (%) | |||
Present | 7 (100) | 0 (0) | < 0.01 |
Absent | 0 (0) | 7 (100) | |
MIB-1 (a.u.) | 4.2 ± 3.0 (1–8.8) | 19.2 ± 6.7 (12–31) | < 0.001 |
The monoclonal antibody MIB-1 was used to determine the Ki-67 labelling index as a marker of proliferation. Continuous values are expressed as mean ± SD with range in parentheses
aMutations involving isocitrate dehydrogenase 1